Dw. Lu et al., SEVERE VISUAL-LOSS AFTER AUTOLOGOUS BLOOD INJECTION FOR MITOMYCIN-C-ASSOCIATED HYPOTONOUS MACULOPATHY, Ophthalmic surgery, 28(3), 1997, pp. 244-245
It has been shown that mitomycin-C increases the success rate of trabe
culectomy; however, a rise in the incidence of postoperative complicat
ions has also been reported. Consequently, the use of antimetabolite i
s usually reserved for patients who are at high risk of surgical failu
re or for patients with advanced glaucoma in whom low intraocular pres
sure is desired. This report describes a patient who suffered severe v
isual loss which was a direct result of hypotonous maculopathy after t
rabeculectomy with mitomycin-C and various other complications from th
e subsequent interventions.